Nursing Elites

1. A weight reduction regimen calls for a daily intake of 1400 kilocalories, which includes 30 grams of fat. What percentage of the total energy is contributed by fat?

• A. 8.50%
• B. 15.00%
• C. 19.00%
• D. 25.50%

Correct answer: C

Rationale: To calculate the percentage of total energy contributed by fat, first determine the energy from fat by multiplying the fat amount (30g) by the energy density of fat (9 kcal/g), which equals 270 kcal. Then, divide the energy from fat (270 kcal) by the total energy intake (1400 kcal) and multiply by 100 to find the percentage: (270 kcal / 1400 kcal) * 100 = 19.29% ≈ 19.00%. Therefore, fat contributes approximately 19% of the total energy in the diet. Choice A (8.50%) is too low, while choices B (15.00%) and D (25.50%) are incorrect calculations based on the given information.

2. What is the primary source of energy for the brain and nervous system?

• A. Protein
• B. Fat
• C. Carbohydrate
• D. Glucose

Correct answer: D

Rationale: Glucose is the correct answer as it is the primary source of energy for the brain and nervous system. The brain relies heavily on glucose to function optimally. While protein and fat play essential roles in the body, they are not the primary sources of energy for the brain and nervous system. Carbohydrates, on the other hand, are broken down into glucose, which is then used as fuel by the brain and nervous system.

3. What is one benefit of using a large sample size in an experiment?

• A. Chance variation is less likely to affect the results.
• B. The possibility of a placebo effect is eliminated.
• C. The experiment will be double-blind.
• D. The control group will be similar to the experimental group.

Correct answer: A

Rationale: Corrected Rationale: Using a large sample size reduces the likelihood of chance variation affecting the results, providing more reliable data. Choice B is incorrect because the placebo effect is related to participants' beliefs, not sample size. Choice C is incorrect as double-blind refers to a method of reducing bias, not directly related to sample size. Choice D is incorrect because the similarity between the control and experimental groups is not solely dependent on sample size.

4. What is one major weakness of a laboratory-based study?

• A. The costs are typically prohibitive.
• B. Findings are difficult to replicate.
• C. Results from animal testing cannot be applied to human beings.
• D. Experimental variables cannot be easily controlled.

Correct answer: C

Rationale: One major weakness of laboratory-based studies is that results from animal testing cannot always be applied to human beings. This limitation arises due to the inherent biological differences between animals and humans, making the generalization of findings challenging. While costs may be a concern in some cases, they do not represent a universal weakness of laboratory-based studies. Findings in such studies can be replicated to ensure validity, and experimental variables can be effectively controlled in a laboratory setting. Choice C is the correct answer because the translatability of results from animal studies to humans is a significant challenge in laboratory-based research, impacting the direct application of findings to human health and well-being.

5. What is the most effective therapy for maintaining remission of acute lymphoblastic leukemia?

• A. Surgery to remove enlarged lymph nodes
• B. Long-term chemotherapy
• C. Nutritional supplements to enhance blood cell production
• D. Blood transfusions to replace ineffective red cells

Correct answer: B

Rationale: The correct answer is B: Long-term chemotherapy. Long-term chemotherapy, specifically with methotrexate, is the most effective therapy for maintaining remission in acute lymphoblastic leukemia. Surgery to remove enlarged lymph nodes (Choice A) is not the primary treatment for leukemia. Nutritional supplements (Choice C) may support overall health but are not the mainstay therapy for maintaining leukemia remission. Blood transfusions (Choice D) are used to address anemia in some cases but are not the primary treatment for maintaining remission in acute lymphoblastic leukemia.

Similar Questions